Bayer AG
XETRA:BAYN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Intrinsic Value
The intrinsic value of
Bayer AG (BAYN) under the Base Case is EUR per share.
Compared with the current market price of 53.36 EUR, the stock appears .
The intrinsic value is calculated using the DCF method.
Do our valuations actually work? See backtest results .
What one share is worth in the bear, base and bull cases.
Create a free account · No card needed
Do our valuations actually work? See backtest results .
Fundamental Analysis
What Bayer Does
Bayer AG is a life sciences company that makes medicines and crop protection products. In human health, it sells prescription drugs and consumer health products used for areas like heart disease, women’s health, eye care, and pain relief. In agriculture, it sells seeds, traits, herbicides, fungicides, and digital farming tools that help farmers protect crops and improve yields.
- Headquarters
- Germany DE
- Employees
- 88 078
- IPO date
- Nov 28, 1997
Bayer has no economic moat
Patent protection gives Bayer an advantage in some medicines, but it does not prevent cheaper copies from taking business once that protection ends. Competition from generic medicines and crop chemicals limits Bayer’s ability to keep charging higher prices across its businesses.
Read the full moat analysisBalance Sheet
Recent Events
Latest Earnings Call
After nine-month momentum, Bayer upgraded several 2026 outlooks, with Pharma leading performance as management kept litigation resolution and faster innovation in focus.
Open the earnings call- Stock, day of the call
- +3.6%
Past 12 months
Continue BAYN Research
Decided on Bayer? Get an email when BAYN reaches the price you’d buy at. Free with an account.
Other Bayer listings
What is the Intrinsic Value of one BAYN stock?
The intrinsic value for
Bayer AG (BAYN) under the Base Case is EUR.
Is BAYN stock undervalued or overvalued?
Compared with the current market price of 53.36 EUR, the stock appears .